NCT05529030

Brief Summary

The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-19 booster of different framing approaches in a survey question sent to employees of a large, rural health system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12,036

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 6, 2022

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2022

Completed
Last Updated

September 30, 2022

Status Verified

September 1, 2022

Enrollment Period

14 days

First QC Date

September 1, 2022

Last Update Submit

September 28, 2022

Conditions

Keywords

CommunicationSurveys and QuestionnairesVaccinationEconomics, Behavioral

Outcome Measures

Primary Outcomes (1)

  • Count of employees who indicate interest in the booster

    Number of employees who indicate that they plan to get the booster when it is available

    14 days

Study Arms (4)

Standard question

NO INTERVENTION

Question with no additional text or framing

Question with salient Omicron message

EXPERIMENTAL

Question indicates that the bivalent booster can protect the respondent from the Omicron variant

Behavioral: Salience of Omicron variantBehavioral: Self-protection message

Question with patient protection message

EXPERIMENTAL

Question indicates that the bivalent booster can protect patients (only presented to patient-facing employees)

Behavioral: Other-protection message

Question with salient Omicron and patient protection message

EXPERIMENTAL

Question indicates that the bivalent booster can protect patients from the Omicron variant (only presented to patient-facing employees)

Behavioral: Salience of Omicron variant

Interventions

The message mentions the Omicron variant, which can be a fear appeal or make salient the reason for the new booster

Question with salient Omicron and patient protection messageQuestion with salient Omicron message

The message makes a reference to protecting one's self

Question with salient Omicron message

The message makes a reference to protecting others (patients)

Question with patient protection message

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Employee at the health system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geisinger Clinic

Danville, Pennsylvania, 17822, United States

Location

MeSH Terms

Conditions

Vaccination RefusalCommunicationBehavior

Condition Hierarchy (Ancestors)

Treatment RefusalTreatment Adherence and ComplianceHealth Behavior

Study Officials

  • Michelle N Meyer, PhD

    Geisinger Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not know that there are different versions of surveys
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Faculty Co-Director, Behavioral Insights Team, Geisinger Clinic

Study Record Dates

First Submitted

September 1, 2022

First Posted

September 6, 2022

Study Start

September 1, 2022

Primary Completion

September 15, 2022

Study Completion

September 15, 2022

Last Updated

September 30, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will share

Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency. This will include the essential data and code needed to replicate the analysis that yielded reported findings.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
By the paper's online publication date. Data will remain available for as long as the Open Science Framework hosts it.
Access Criteria
The data on the Open Science Framework will be open to anyone requesting that information.

Locations